Guangliang Li - Publications

Affiliations: 
2020- Immunology Tianjin Medical University, China 

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Zhu H, Li G, Yin J, Zhang H, Da Y, Li L. Anlotinib attenuates experimental autoimmune encephalomyelitis mice model of multiple sclerosis modulating the differentiation of Th17 and Treg cells. Immunopharmacology and Immunotoxicology. 1-9. PMID 35638564 DOI: 10.1080/08923973.2022.2071722  0.547
2019 Li H, Hong W, Jin X, Li G, Zhou G, Fan L. The aryl hydrocarbon receptor is a novel negative regulator of interleukin-17-mediated signaling and inflammation in vitro. Febs Letters. PMID 30953345 DOI: 10.1002/1873-3468.13380  0.457
2016 Lu H, Li G, Zhou C, Jin W, Qian X, Wang Z, Pan H, Jin H, Wang X. Regulation and role of post-translational modifications of enhancer of zeste homologue 2 in cancer development. American Journal of Cancer Research. 6: 2737-2754. PMID 28042497  0.342
2012 Chen Y, Duan Y, Kang Y, Yang X, Jiang M, Zhang L, Li G, Yin Z, Hu W, Dong P, Li X, Hajjar DP, Han J. Activation of liver X receptor induces macrophage interleukin-5 expression. The Journal of Biological Chemistry. 287: 43340-50. PMID 23150660 DOI: 10.1074/jbc.M112.403394  0.355
Show low-probability matches.